Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
DePuy Orthopaedics
The study will evaluate the clinical performance of rotating platform and fixed bearing cruciate ligament substituting implants by obtaining a series of primary TKAS. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System or P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System and assignment is randomized.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Osteoarthritis
Rheumatoid arthritis
Other inflammatory arthritis
Avascular necrosis (AVN) of bone
Post-Traumatic Arthritis
Juvenile Rheumatoid Arthritis
You may not be if
History of recent/active joint sepsis.
Charcot neuropathy.
Psycho-social disorders that would limit rehabilitation.
Greater than 75 years of age at the time of surgery.
Prior ipsilateral knee arthroplasty.
Metabolic disorders of calcified tissues, such as Paget's disease.
Severe diabetes mellitus.
Joint replacement due to autoimmune disorders.
Skeletal immaturity
Clareo Health | Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA
